2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Saturday, April 29, 2017

5:30pm-7:30pm: C3d-Binding Anti-DQ DSA Is Associated with a High Risk for Late ABMR and Graft Failure in Stable Kidney Transplant Recipients.

D. Lee,¹ B. Kim,² J. Kim,³ I. Kim,⁴ M. Chun.⁵

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I • Hall D1

5:30pm-7:30pm: Can Pre-Treatment CDC Titres Predict Graft Outcomes in HLA Incompatible Transplants?

A. Prasad,¹ A. Yuvaraj,¹ D. Briggs,² N. Krishnan.¹

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I • Hall D1

5:30pm-7:30pm: CD4 T Cell Depletion Mitigates Ischemic Hepatocellular Damage and Promotes Immune Regulation in Mouse Liver Allografts.

S. Kageyama, K. Nakamura, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai.

Poster Session A: Ischemic Injury and Organ Preservation Session I • Hall D1

5:30pm-7:30pm: Charlson Comorbidity Index (CCI) as Prognostic Indicator of Outcomes in Older Patients Undergoing Renal Transplantation.

A. Asderakis, U. Contractor, U. Khalid, P. Donato, L. Szabo.

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1

5:30pm-7:30pm: Chronic Antibody Mediated Rejection (cABMR) in ABO-Incompatible and ABO-Compatible Kidney Transplants: A Single US Center Experience.

S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I • Hall D1

5:30pm-7:30pm: Chronic Hepatitis E-Genotype 3 Infection in Transplant Recipients: A Single Kidney and Pancreas Transplant Centre Experience.

A. Kousios,¹ R. Charif,¹ E. Sanchez,² S. Khan,³ F. Regan,⁴ S. Ijaz,⁵ D. Muir,² B. Smith,³ R. Tedder,⁵ D. Taube,¹ J. Galliford.¹

Poster Session A: Kidney Complications I • Hall D1

5:30pm-7:30pm: Cibinetide (ARA 290), the Innate Repair Receptor Ligand, Improves Engraftment in Pancreatic Islet Transplantation by Protecting Islets and Reducing Inflammatory Reactions.

M. Watanabe,¹ M. Han Yao,¹ H. Zemack,¹ B.-G. Ericzon,¹ A. Cerami,² M. Brines,² T. Lundgren,¹ M. Kumagai-Braesch.¹

Poster Session A: Cellular & Bone Marrow Transplantation Session I • Hall D1

5:30pm-7:30pm: Ciprofloxacin for Urinary Tract Infection Prophylaxis in Post-Renal Transplant Patients with Ureteral Stent Placement.

P. Kakadiya, M. Levy, G. Gupta, A. King, S. LeCorchick.

Poster Session A: Kidney Complications I • Hall D1

5:30pm-7:30pm: Circulating Donor-Specific Memory B Cells (mBc) Discriminates Kidney Transplant Patients with Histological Lesions of ABMR in Absence of Circulating DSA.

S. Luque,² M. Lúcia,⁴ M. Jarque,² E. Crespo,² E. Melilli,¹ J. Martorell,³ J. Cruzado,^1,2 J. Torras,^1,2 J. Grinyó,^1,2 O. Bestard.^1,2

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I • Hall D1

5:30pm-7:30pm: Clearance of Transaminases During Normothermic Ex Vivo Liver Perfusion.

M. Bral,¹ N. Aboelnazar,² B. Gala-Lopez,² S. Hatami,² D. Freed,¹ A. Shapiro.¹

Poster Session A: Ischemic Injury and Organ Preservation Session I • Hall D1